Encompass Health Corporation with ticker code (EHC) have now 9 market analysts covering the stock. The analyst consensus now points to a rating of ‘strong_buy’. The range between the high target price and low target price is between $85.00 and $77.00 suggesting an average Analsyt target price of $81.11. Now with the previous closing price of $63.90 this would imply there is now a potential upside of 26.9%. It’s also worth noting that there is a 50 day moving average of $65.37 and the 200 moving average now moves to $63.55. The company has a market cap of 6.40B. The current share price for the company is: $63.83 USD
The potential market cap would be $8,121,640,901 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 17.98, revenue per share of $47.19 and a 7.88% return on assets.
Encompass Health Corporation is a provider of post-acute healthcare service. The Company manages its operations through its inpatient rehabilitation segment. The Company is the owner and operator of rehabilitation hospitals. It operates hospitals in approximately 37 states and Puerto Rico, with concentrations in the eastern half of the United States and Texas. The Company operates approximately 156 inpatient rehabilitation hospitals. It provides specialized rehabilitative treatment on an inpatient basis. The Company’s inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It also provides rehabilitative care for patients recovering from injury or illness, using advanced technology and treatments to maximize recovery. Its hospitals provide a comprehensive interdisciplinary clinical approach to treatment that leverages technologies and advanced therapies and leads to superior outcomes.
